Clinical Trial Update: Molecular Evaluation of TAAR1 and JAK/STAT Pathway in Hidradenitis Suppurativa

View source ↗

Summary

A completed clinical trial assessing molecular markers related to TAAR1 and the JAK/STAT pathway in hidradenitis suppurativa and related skin inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Snippet

Sponsor: Trakya University | Conditions: Hidradenitis Suppurativa (HS), Skin Inflammation | Status: COMPLETED